EGFR and lung carcinoma: For example, the polymorphism of BCL-2-like 11 (BIM), a pro-apoptotic member of the BCL2 family, is reportedly sufficient to confer intrinsic resistance to first-generation EGFR-TKIs in lung cancers [92].